Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.77 USD | +3.54% | -9.98% | +1.49% |
Evolution of the average Target Price on Aprea Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Aprea Therapeutics, Inc.
Wedbush | |
Maxim | |
HC Wainwright | |
Berenberg Bank | |
RBC Capital Markets | |
JPMorgan Chase | |
Morgan Stanley |
EPS Revisions
- Stock Market
- Equities
- APRE Stock
- Consensus Aprea Therapeutics, Inc.